MedPath

Identification of Protein markers in ovarian cancer

Not Applicable
Recruiting
Conditions
Ovarian Cancer
Cancer - Ovarian and primary peritoneal
Registration Number
ACTRN12608000519358
Lead Sponsor
Ovarian cancer research fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Patients who have known Ovarian cancer diagnosed from a previous pathology specimen OR Patients with an Ovarian mass which may be beningn or malignat.

Exclusion Criteria

Inability to give consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To measure the different protein levels in ovarian cancer tissue, urine, plasma and uterine lavage. Advanced proteiomic method will be use to identify cancer specific proteins from the collected specimens[Specimens will be collected and will be stored untill 500 participants are recruited and than specimens will be processed];Identification of cancer-specific protein markers for the early detection of Ovarian Cancer[End of the data anlysis phase]
Secondary Outcome Measures
NameTimeMethod
one[None]
© Copyright 2025. All Rights Reserved by MedPath